Clinica Chimica Acta, Journal Year: 2025, Volume and Issue: 571, P. 120243 - 120243
Published: March 14, 2025
Language: Английский
Clinica Chimica Acta, Journal Year: 2025, Volume and Issue: 571, P. 120243 - 120243
Published: March 14, 2025
Language: Английский
International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(4), P. 1621 - 1621
Published: Feb. 14, 2025
Tuberculosis (TB) remains one of the most challenging infectious diseases, with Mycobacterium tuberculosis (Mtb) employing sophisticated mechanisms to evade host immunity and establish persistent infections. This review explores recent advances in understanding Mtb's immune evasion strategies; granuloma dynamics; emerging immunotherapeutic approaches. Key findings highlight manipulation autophagy; metabolic reprogramming; cytokine pathways by Mtb sustain its survival within cells. Insights into formation reveal critical role bacterial lipids; modulation; hypoxia-driven dormancy maintaining chronic infection. Innovative therapeutic strategies, including host-directed therapies; epigenetic interventions; immunomodulators, hold promise for improving TB management combating drug-resistant strains. Despite these advancements, significant challenges remain, development effective vaccines; addressing latent TB; ensuring equitable access novel treatments. The integration advanced technologies such as artificial intelligence multi-omics approaches, alongside global collaboration, is essential overcome hurdles. underscores importance a multidisciplinary approach tackling TB, ultimate goal eradicating this health threat.
Language: Английский
Citations
1Clinical Reviews in Allergy & Immunology, Journal Year: 2025, Volume and Issue: 68(1)
Published: Feb. 20, 2025
Language: Английский
Citations
0Clinica Chimica Acta, Journal Year: 2025, Volume and Issue: 571, P. 120243 - 120243
Published: March 14, 2025
Language: Английский
Citations
0